Pelacarsen fails to prevent heart attacks

An-Nahar: A trial of pelacarsen lowers lipoprotein(a) by 77%, but fails to reduce heart attacks and strokes, opening the door to scientific questions…
Machine translation of an attributed source excerpt. Consult the original report to verify details. Translated from original reporting in another language.
/file/attachments/2415/eb9e1550-5019-4103-b82d-73443c12d52a_809652.jpeg)

